| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 22,4 k € | -40.9% | 37,9 k € | +42.1% | 26,7 k € | -57.6% | 62,9 k € | -37.2% | 100,2 k € | +16.4% | 86,0 k € | -26.1% | 116,4 k € | +23.2% | 94,5 k € | -45.3% | 172,9 k € | +95.5% | 88,4 k € | -56.2% | 202,0 k € | +126.7% | 89,1 k € | -65.7% | 259,6 k € | -68.6% | 827,4 k € | +360.8% | 179,6 k € | -31.2% | 261,0 k € | +273.5% | 69,9 k € | -32.8% | 104,0 k € | +124.7% | 46,3 k € | |
| EBITDA | 13,4 k € | -59.9% | 33,3 k € | +137.3% | 14,0 k € | -74.9% | 56,0 k € | -36.2% | 87,7 k € | +14.9% | 76,3 k € | -28.9% | 107,3 k € | +22.6% | 87,5 k € | -43.4% | 154,5 k € | +91.2% | 80,8 k € | -55.2% | 180,4 k € | +119.4% | 82,2 k € | -61.1% | 211,3 k € | -72.0% | 754,6 k € | +331.6% | 174,8 k € | -31.6% | 255,5 k € | +298.2% | 64,2 k € | -34.9% | 98,6 k € | +133.5% | 42,3 k € | |
| Operating profit | -3,5 k € | -121.0% | 16,5 k € | +689.2% | -2,8 k € | -107.1% | 39,1 k € | -37.9% | 63,0 k € | +24.3% | 50,7 k € | -38.0% | 81,7 k € | +57.4% | 51,9 k € | -53.2% | 110,9 k € | +198.5% | 37,2 k € | -72.8% | 136,7 k € | +263.2% | 37,6 k € | -77.2% | 164,9 k € | -76.8% | 710,9 k € | +398.1% | 142,7 k € | -33.2% | 213,7 k € | +856.3% | 22,3 k € | -59.3% | 54,9 k € | +13017.7% | -424,9 € | |
| Profit/loss | -104,9 k € | -2183.6% | 5,0 k € | +105.0% | -100,2 k € | -85.8% | -53,9 k € | -210.7% | -17,4 k € | +65.8% | -50,7 k € | -98.3% | -25,6 k € | -136.1% | -10,8 k € | -119.0% | 57,1 k € | +313.2% | -26,8 k € | -128.6% | 93,7 k € | +707.9% | 11,6 k € | -95.2% | 243,3 k € | -62.8% | 653,1 k € | +483.1% | 112,0 k € | +12.6% | 99,4 k € | +873.6% | -12,9 k € | +47.9% | -24,7 k € | +48.8% | -48,2 k € | |
| Equity | -2,4 k € | -102.4% | 102,5 k € | +5.2% | 97,5 k € | -50.7% | 197,7 k € | -21.4% | 251,7 k € | -6.5% | 269,0 k € | -15.9% | 319,8 k € | -7.4% | 345,4 k € | -3.0% | 356,2 k € | +8.2% | 329,1 k € | -7.5% | 355,9 k € | 0.0% | 355,9 k € | 0.0% | 355,9 k € | +73.1% | 205,6 k € | 0.0% | 205,6 k € | +2.8% | 199,9 k € | +99.0% | 100,5 k € | -10.5% | 112,3 k € | -18.0% | 137,0 k € | |
| Total assets | 1,6 M € | -26.5% | 2,1 M € | -11.6% | 2,4 M € | -13.4% | 2,8 M € | +12.8% | 2,5 M € | -4.0% | 2,6 M € | +7.0% | 2,4 M € | -2.4% | 2,5 M € | +4.6% | 2,4 M € | +5.4% | 2,2 M € | -3.9% | 2,3 M € | +8.0% | 2,2 M € | +5.5% | 2,0 M € | -14.1% | 2,4 M € | +40.6% | 1,7 M € | -11.6% | 1,9 M € | +5.0% | 1,8 M € | -6.0% | 1,9 M € | -3.2% | 2,0 M € | |
| Cash | 68,3 k € | -64.6% | 193,1 k € | +128.8% | 84,4 k € | -30.2% | 120,8 k € | +358.2% | 26,4 k € | -49.4% | 52,1 k € | +157.7% | 20,2 k € | -8.7% | 22,1 k € | -38.6% | 36,1 k € | +6.8% | 33,8 k € | -60.3% | 85,0 k € | -14.9% | 99,9 k € | +11.4% | 89,7 k € | -14.9% | 105,4 k € | +48.3% | 71,1 k € | +60.2% | 44,4 k € | -23.6% | 58,1 k € | +22.8% | 47,3 k € | -54.3% | 103,4 k € | |
| Debts | 1,6 M € | -22.7% | 2,0 M € | -12.3% | 2,3 M € | -10.5% | 2,6 M € | +16.7% | 2,2 M € | -3.7% | 2,3 M € | +10.6% | 2,1 M € | -1.6% | 2,1 M € | +5.9% | 2,0 M € | +4.9% | 1,9 M € | -3.3% | 2,0 M € | +9.5% | 1,8 M € | +8.8% | 1,7 M € | -23.9% | 2,2 M € | +46.2% | 1,5 M € | -13.3% | 1,7 M € | -0.5% | 1,7 M € | -5.7% | 1,8 M € | -2.1% | 1,9 M € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 1 | — | — | — | — | — | — | — | — | |||||||||||||||||||
Public limited company · Grimbergen · incorporated on 07/08/2000
Public limited company loss-making in the latest fiscal year. Cash position declining (-64.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
RING PHARMA is a Public limited company incorporated in 2000. Its main activity is: Market research and public opinion polling. Its registered office is in Grimbergen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette